Gordon Ramsay Slams Ozempic Menus
Gordon Ramsay publicly criticized the rise of "Ozempic-inspired" restaurant menus designed for weight-loss drug users, calling the trend "stupid" and warning against letting such fads dictate culinary creativity. The controversy highlights the tension between health trends and traditional dining experiences in the restaurant industry.
- In a profanity-laced statement, Gordon Ramsay elaborated on his position by saying diners are responsible for "eating too much in the first f*ing place" and that he had no intention of introducing a special menu to "make you feel like less of a fat f*". - Ramsay’s stance contrasts with other celebrity chefs, such as Heston Blumenthal, who introduced a reduced-portion "mindful experience" menu at his three-Michelin-starred restaurant, The Fat Duck, in response to the trend. - The trend extends beyond fine dining, with chains like Chipotle, Shake Shack, and Smoothie King introducing high-protein or "GLP-1 Friendly" menu items to cater to customers with reduced appetites. - Some restaurants that have adopted smaller-portion menus, like The Banc in Dubai and Tucci in New York, did so after observing an increase in food waste and receiving direct requests from customers for smaller dishes. - Data from retailers like Walmart indicates that users of GLP-1 drugs purchase fewer groceries, particularly snacks and sweets, prompting food manufacturers to develop new product lines with reduced sugar and smaller portions. - Market analysis predicts that the widespread use of these medications could lead to a 20-30% reduction in daily calorie intake for users and a potential 4% decline in consumption of soft drinks, alcohol, and salty snacks by 2035. - Ramsay connected his frustration with "Ozempic menus" to what he sees as a broader trend of increasingly complicated customer demands over the past few decades, such as a rise in celiac disease and other dietary requirements.
